• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Arrowhead Gets TGA Approval for Plozasiran in FCS in Australia

    FIRSTWORD PHARMA

    EU Backs Arrowhead’s REDEMPLO for Rare Lipid Disorder

    BUSINESSWIRE

    Arrowhead Pharma Gets NMPA Nod For REDEMPLO In China For FCS

    BUSINESSWIRE

    Health Canada Approves Arrowhead`s REDEMPLO for Adult FCS

    BUSINESSWIRE

    FDA Approves Arrowhead`s Genetic Disorder Drug

    FDA

    Arrowhead Launches FCS Resources On Rare Disease Day

    BUSINESSWIRE

    Arrowhead targets rare disease patients with awareness campaign

    FIERCE PHARMA

    Arrowhead up 5% after hours after Vertex abandons rare disease drug

    SEEKING ALPHA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.